US Broker Ratings

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Exploring the 8.21% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a leading medical technology company, has been making waves in the healthcare sector with its robust portfolio of orthopedic reconstructive products and cutting-edge surgical..

HCA Healthcare, Inc. (HCA) Stock Analysis: Evaluating a 25.98% Potential Upside for Investors

HCA Healthcare, Inc. (NYSE: HCA), a titan in the healthcare sector, commands attention from investors with its substantial market capitalization of $82.34 billion. Operating in the medical care facilities industry,..

Eli Lilly (LLY) Stock Analysis: Strong Revenue Growth and Analyst Optimism Fuel Potential Upside

Eli Lilly and Company (NYSE: LLY) stands out in the healthcare sector as a pharmaceutical powerhouse with a robust market capitalization of $1.05 trillion. Known for its innovative approach in..

DexCom, Inc. (DXCM) Stock Analysis: Strong Buy Ratings and Promising Growth Potential

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector’s medical device industry, continues to capture the attention of investors with its innovative continuous glucose monitoring (CGM) systems. With a..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring a 25.79% Potential Upside

For investors seeking opportunities in the healthcare sector, GE HealthCare Technologies Inc. (NYSE: GEHC) presents an intriguing prospect. With a market capitalization standing at $28.69 billion, this Chicago-based medical device..

Labcorp Holdings Inc. (LH): Investor Outlook with a 10% Upside Potential

Labcorp Holdings Inc. (NYSE: LH), a stalwart in the healthcare sector, operates at the intersection of diagnostics and research, offering a wide range of laboratory services and tests. With a..

Abbott Laboratories (ABT) Stock Analysis: Exploring a 17.53% Potential Upside in the Healthcare Sector

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, has long been a trusted name in medical devices and pharmaceuticals. With a market capitalization of $175.37 billion, Abbott is..

BeOne Medicines Ltd. (ONC) Stock Analysis: Strong Buy Ratings and Potential 32.95% Upside

BeOne Medicines Ltd. (NASDAQ: ONC), a prominent player in the biotechnology sector, is capturing investor attention with its robust pipeline of oncology treatments and a strong market presence across the..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: A 22.51% Potential Upside with a Strong Buy Consensus

Takeda Pharmaceutical Company L (NYSE: TAK), a titan in the healthcare sector, presents a compelling investment opportunity for those looking to capitalize on its position within the global pharmaceutical landscape...

Novo Nordisk A/S (NVO) Stock Report: Navigating Growth with a 24% Revenue Surge

Novo Nordisk A/S (NVO), a global leader in the healthcare sector, continues to draw investor attention with its impressive revenue growth of 24%. This Denmark-based pharmaceutical titan, with a market..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a Potential 49.90% Upside in the Animal Health Sector

Zoetis Inc. (NYSE: ZTS), a dominant player in the healthcare sector specializing in animal health, presents an intriguing investment opportunity for those seeking exposure to the growing needs of both..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Navigating a 46% Upside Potential with Innovative Medical Technology

Intuitive Surgical, Inc. (NASDAQ: ISRG), a pioneer in the medical instruments and supplies industry, continues to capture the attention of investors with its cutting-edge technologies and significant market presence. With..

Pfizer Inc. (PFE) Stock Analysis: Evaluating a 14.92% Potential Upside Amidst Strong Dividend Yield

For investors keeping a close eye on the healthcare sector, Pfizer Inc. (NYSE: PFE) presents an intriguing proposition. As a stalwart in the global pharmaceutical industry, Pfizer’s current market position,..

Amgen Inc. (AMGN) Stock Analysis: Evaluating Growth Potential in the Healthcare Sector

Amgen Inc. (NASDAQ: AMGN), a heavyweight in the healthcare sector with a market capitalization of $197.69 billion, continues to garner attention from investors seeking stability and growth in their portfolios...

Elevance Health, Inc. (ELV) Stock Analysis: Unlocking a 20.37% Potential Upside with Solid Fundamentals

For investors eyeing the healthcare sector, Elevance Health, Inc. (ELV) offers a compelling opportunity with a notable potential upside of 20.37% based on current analysts’ target price projections. As a..

CVS Health Corporation (CVS) Stock Analysis: Navigating Growth with a 4.14% Upside Potential

CVS Health Corporation (NYSE: CVS), a giant in the healthcare sector, continues to draw attention from investors with its robust presence in the healthcare plans industry. With a market cap..

Merck & Co., Inc. (MRK) Stock Analysis: Navigating a 5.13% Upside Potential Amid Robust Growth

Merck & Co., Inc. (NYSE: MRK), a titan in the healthcare sector and a leader in drug manufacturing, continues to captivate investors with its strategic growth and promising financial metrics...

GSK plc (GSK) Stock Analysis: Exploring a 12.21% Upside Potential in the Healthcare Giant

GSK plc (NYSE: GSK), a stalwart in the global healthcare sector, commands a market capitalization of $103.66 billion and stands as a key player in the drug manufacturing industry with..

UnitedHealth Group (UNH) Stock Analysis: Navigating a 10.69% Potential Upside with Strong Analyst Confidence

UnitedHealth Group Incorporated (NYSE: UNH) stands as a formidable player in the healthcare sector, specifically within the healthcare plans industry. With a market capitalization of $386.95 billion, this Minnesota-based giant..

Stryker Corporation (SYK) Investor Outlook: A 20.84% Potential Upside to Watch in the Medical Device Sector

Stryker Corporation (NYSE: SYK), a leading player in the healthcare sector, specifically within the medical devices industry, presents a compelling narrative for investors seeking both stability and growth. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds